Skip to main content
Behind the scenes of a billion dollar pharma deal
Insights

Behind the scenes of a billion dollar pharma deal

On 9 June 2020 Eli Lilly and Evox Therapeutics inked a neuroscience therapy deal worth $1.2 billion.

In this webinar two of the key players in that deal will take you behind-the-scenes to explain how Evox got on Lilly’s radar, explore the challenges of forming a partnership under a COVID-19 lockdown, and recall the discussions and internal debates that led to one of the biggest biopharma deals of the year so far.

Go behind the scenes with:

Raymond Jordt
Raymond Jordt
Former Vice President of Corporate Business Development at Eli Lilly
Simon Dew
Simon Dew
Former Vice President of Business Development at Evox Therapeutics

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Product updates
Help center
Excellence calculator
Labiotech.eu
Company
About us
Contact us
© 2023 Inpart Privacy policy Terms of use